| Outcome Measures: |
Primary: Time in range within 6 hours, Percentage of time with CGM glucose between 4.0 - 10.0 mmol/L within 6 hours after the start of high-intensity or moderate-intensity, in-clinic exercise, 6 hours | Secondary: Change in glucose within 60 mins after high-intensity exercise starts, Plasma glucose at 30 mins after after the end of a 30-min high-intensity, in-clinic exercise minus plasma glucose at baseline (right before exercise), 60 mins|Change in glucose within 120 mins after moderate-intensity exercise starts, Plasma glucose at 30 mins after the end of a 90-min moderate-intensity, in-clinic exercise minus plasma glucose at baseline (right before exercise), 120 mins|Time spent in hypoglycemia 24 hours after exercise, Percentage of time with CGM glucose \<4.0 mmol/L within 24 hour after the start of high intensity exercise or moderate intensity in-clinic exercise, 24 hours|Time in range 24 hours after exercise, Percentage of time with CGM glucose between 4.0 - 10.0 mmol/L within 24 hour after the start of high intensity exercise or moderate intensity in-clinic exercise, 24 hours|Time spent in hyperglycemia 24 hours after exercise, Percentage of time with CGM glucose \> 10.0 mmol/L within 24 hour after the start of high intensity exercise or moderate intensity in-clinic exercise, 24 hours|Time in range in the last 4 weeks of each study phase, Percentage of time with CGM glucose between 4.0 - 10.0 mmol/L in the last 4 weeks of each study phase, 4 weeks|Frequency of hypoglycemia 24 hours after exercise, Number of hypoglycemic episodes, which are defined as CGM glucose \<4.0 mmol/L lasting ≥15 minutes within 24 hours following high intensity exercise or moderate intensity in-clinic exercise, 24 hours|Frequency of hypoglycemia in the last 4 weeks of each study phase, Number of hypoglycemic episodes, which are defined as CGM glucose \<4.0 mmol/L lasting ≥15 minutes in the last 4 weeks of each study phase, 4 weeks|Change in Diabetes Medication Satisfaction (DiabMedSat) Score, Diabetes Medication Satisfaction questionnaire is to measure the level of patients' satisfaction with their diabetes medication(s) in the past 2 weeks. The score range will be 0 to 100. The higher the score, the less the satisfaction. The change of scores is the score difference between Visit 24 and Visit 2, 11 weeks|Change in Hypoglycemia Fear Score, Hypoglycemia Fear will be measured by the Hypoglycemia Fear Survey which assesses the subject's behaviors to avoid hypoglycemia and to measure the subjects' worries about hypoglycemia and its consequences in the past 3 months. The range of the score will be 0 to 132. The higher the score, the greater the fear. The changes of scores are the score difference between Visit 24 and Visit 2, 11 weeks|Change in TRIM-D Score, Treatment Related Impact Measure - Diabetes Device (TRIM-D Device) questionnaire will be used to generate TRIM-D-Score. It measures the level of the subject's satisfaction with the device used to take the diabetes medication. The range of this score will be 3-15. The higher the score, The greater satisfaction. The changes of scores are the score difference between Visit 24 and Visit 2, 11 weeks
|
